New approaches in the development of a vaccine for mucosal candidiasis: progress and challenges.

New approaches in the development of a vaccine for mucosal candidiasis: progress and challenges.

The commensal fungus Candida albicans causes mucosal candidiasis in the rapidly expanding number of immunocompromised patients. Mucosal candidiasis includes orapharyngeal, esophageal, gastrointestinal, and vaginal infections. Vulvovaginal candidiasis (VVC) and antimycotic-refractory recurrent VVC is...

Full description

Bibliographic Details
Main Authors: Anna eVecchiarelli, Eva ePericolini, Elena eGabrielli, Donatella ePietrella
Format: Article
Language:English
Published: Frontiers Media S.A. 2012-08-01
Series:Frontiers in Microbiology
Subjects:
Candidiasis
Vaccine
Fungal infections
mucosal candidiasis
C. albicans
Online Access:http://journal.frontiersin.org/Journal/10.3389/fmicb.2012.00294/full

Internet

http://journal.frontiersin.org/Journal/10.3389/fmicb.2012.00294/full

Similar Items